Is GE HealthCare Technologies (GEHC) A Bargain On Its Mayo Clinic MI BET Study News?

Simply Wall St.07-13 06:26

GE HealthCare Technologies (GEHC) drew fresh attention after announcing the MI-BET research collaboration with Mayo Clinic, a theranostics study focused on more personalized radioligand therapy for ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2651169743?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","is_english":true,"pubTime":"2026-07-13 06:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651169743","market":"nz","top_or_hot":-1,"title":"Is GE HealthCare Technologies (GEHC) A Bargain On Its Mayo Clinic MI BET Study News?","media":"Simply Wall St.","content":"<div>\n<p>GE HealthCare Technologies (GEHC) drew fresh attention after announcing the MI-BET research collaboration with Mayo Clinic, a theranostics study focused on more personalized radioligand therapy for ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-gehc/ge-healthcare-technologies/news/is-ge-healthcare-technologies-gehc-a-bargain-on-its-mayo-cli\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is GE HealthCare Technologies (GEHC) A Bargain On Its Mayo Clinic MI BET Study News?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs GE HealthCare Technologies (GEHC) A Bargain On Its Mayo Clinic MI BET Study News?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-13 06:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-gehc/ge-healthcare-technologies/news/is-ge-healthcare-technologies-gehc-a-bargain-on-its-mayo-cli><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GE HealthCare Technologies (GEHC) drew fresh attention after announcing the MI-BET research collaboration with Mayo Clinic, a theranostics study focused on more personalized radioligand therapy for ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-gehc/ge-healthcare-technologies/news/is-ge-healthcare-technologies-gehc-a-bargain-on-its-mayo-cli\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1066053197.SGD","symbol_name":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gehc/ge-healthcare-technologies/news/is-ge-healthcare-technologies-gehc-a-bargain-on-its-mayo-cli","article_id":"2651169743","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gehc/ge-healthcare-technologies/news/is-ge-healthcare-technologies-gehc-a-bargain-on-its-mayo-cli","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2651169743","pubTimestamp":1783895166,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"GE HealthCare Technologies (GEHC) drew fresh attention after announcing the MI-BET research collaboration with Mayo Clinic, a theranostics study focused on more personalized radioligand therapy for advanced prostate cancer using imaging, biomarkers, and digital tools.\nSee our latest analysis for GE HealthCare Technologies.\nDespite the MI-BET announcement and other product updates, GE HealthCare Technologies’ recent share price momentum has been weak. The stock is at US$64.70, the 90 day share...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","BK4588":"碎股","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","DFEN":"Direxion Daily Aerospace & Defense Bull 3X Shares","NATO":"Themes Transatlantic Defense ETF","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","EXI":"全球工业ETF-iShares","XAR":"SPDR S&P Aerospace & Defense ETF","LU0157215616.USD":"FIDELITY GLOBAL FOCUS \"A\" INC","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","ITA":"iShares Dow Jones U.S. Aerospace","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","LU2756315664.SGD":"ALLIANZ INCOME AND GROWTH \"AMI\" (SGDHDG) INC","LU0149725797.USD":"汇丰美国股市经济规模基金","PPA":"国防航太ETF-PowerShares","LU1066051811.HKD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","BK4543":"AI","LU2168564495.EUR":"AZ ALLOCATION - TREND \"AI\" (EUR) ACC","GEHC":"GE HEALTHCARE TECHNOLOGIES INC","BK4077":"互动媒体与服务","LGHT":"LANGAR GLOBAL HEALTHTECH ETF","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU0689626769.HKD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (HKD) ACC","LU2168564222.USD":"AZ ALLOCATION - TREND \"AAZ\" (USDHDG) ACC","GE":"GE航空航天","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU2168564065.EUR":"AZ ALLOCATION - TREND \"AAZ\" (EUR) ACC","MI":"NFT Limited","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU0353189763.USD":"ALLSPRING  US ALL CAP GROWTH FUND \"I\" (USD) ACC","LU1066051225.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","MISL":"First Trust Indxx Aerospace & Defense ETF","BK4082":"医疗保健设备","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","UXI":"ProShares Ultra Industrials","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU1366333091.USD":"FIDELITY GLOBAL FOCUS \"A\" (USD) ACC","LU0077335932.USD":"FIDELITY AMERICAN GROWTH \"A\" INC","LU0124676726.USD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC","LU2756315318.SGD":"ALLIANZ INCOME AND GROWTH \"AMG\" (SGDHDG) INC A"},"translate_title":"GE HealthCare Technologies (GEHC) 对其梅奥诊所 MI BET 研究新闻很便宜吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DFEN":0.6,"NATO":0.6,"UXI":0.6,"EXI":0.6,"LGHT":0.6,"MISL":0.6,"XAR":0.6,"MI":1.5,"PPA":0.6,"GEHC":1.5,"ITA":0.6,"GE":1.5},"content_text":"GE HealthCare Technologies (GEHC) drew fresh attention after announcing the MI-BET research collaboration with Mayo Clinic, a theranostics study focused on more personalized radioligand therapy for advanced prostate cancer using imaging, biomarkers, and digital tools. See our latest analysis for GE HealthCare Technologies. Despite the MI-BET announcement and other product updates, GE HealthCare Technologies’ recent share price momentum has been weak. The stock is at US$64.70, the 90 day share price return has declined 12.37%, and the 1 year total shareholder return has fallen 13.73%. This suggests that enthusiasm around new initiatives has not yet translated into stronger performance. If this kind of precision medicine work interests you, it could be a good moment to broaden your watchlist with other healthcare focused AI opportunities such as 41 healthcare AI stocks GE HealthCare Technologies now sits well below recent highs despite its MI-BET partnership and product rollouts. Are you looking at a business that is mispriced, or a stock that simply reflects cooler sentiment? AdvertisementMost Popular Narrative: 18.8% Undervalued Against GE HealthCare Technologies' last close of $64.70, the most followed narrative anchors on a fair value of $79.72, framing the stock as materially discounted and tying that view to a detailed set of growth and margin expectations.  The pipeline of new high-impact products, like Radiopharmaceuticals, Total Body PET, and Photon Counting CT, is anticipated to drive future revenue growth and potentially improve margins.  Read the complete narrative. Curious what earnings path and margin profile are baked into that $79.72 fair value for GE HealthCare Technologies? The narrative focuses on steady top line expansion, rising profitability, and a future earnings multiple that is below many current peers. The exact mix of revenue growth, margin uplift, and valuation reset may be different from what you expect. Result: Fair Value of $79.72 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there are still meaningful risks to that GE HealthCare Technologies narrative, including tariff related earnings pressure and ongoing uncertainty around China that could challenge those analyst assumptions. Find out about the key risks to this GE HealthCare Technologies narrative. Next Steps Seeing both optimism and concern around GE HealthCare Technologies in this article, it makes sense to check the underlying data yourself and move quickly to form your own stance by reviewing the balance of 4 key rewards and 1 important warning sign. Looking for more investment ideas beyond GE HealthCare Technologies? Do not stop at GE HealthCare Technologies; use the Simply Wall Street Screener now to uncover fresh stock ideas that match your approach before others move first.  Target potential upside by scanning for companies that look out of favour yet financially sound using the 45 high quality undervalued stocks. Strengthen your income focus by checking out businesses with reliable cash flows supporting payouts through the 9 dividend fortresses. Prioritise resilience by filtering for companies with measured risk profiles and sturdier fundamentals via the 78 resilient stocks with low risk scores.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2651169743","isCrawlerRequest":true}